Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    ald403
Show Display Options
Rank Status Study
1 Completed Safety Tolerability and Pharmacokinetics of ALD403
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Sumatriptan
2 Recruiting A Multicenter Assessment of ALD403 in Chronic Migraine
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Placebo
3 Completed Safety, Efficacy and Pharmacokinetics of ALD403
Condition: Migraine
Intervention: Biological: ALD403
4 Completed Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)
Condition: Hepatitis C Virus
Interventions: Drug: Asunaprevir;   Drug: Daclatasvir;   Drug: Peg-interferon Alfa-2a;   Drug: Ribavirin

Indicates status has not been verified in more than two years